All News | Sandoz

July 2021

Media ReleaseJul 16, 2021
Sandoz launches first generic high dose intravenous iron, Ferumoxytol Injection, to treat US patients with iron deficiency anemia
Patients with iron deficiency anemia in a hospital or clinic setting now have access to an important IV iron medicine at a more affordable price Iron deficiency anemia occurs when there is a lower…

June 2021

Media ReleaseJun 25, 2021
Sandoz announces EU launch of ready-to-dilute generic Pemetrexed to treat most prevalent form of lung cancer
Pemetrexed is indicated for patients with non-squamous Non-Small Cell Lung Cancer (NSCLC), who represent over 3 in 4 patients with lung cancer1 New ready-to-dilute format and 1,000 mg strength…

May 2021

April 2021

Media ReleaseApr 27, 2021
Novartis key growth drivers and launches continue momentum in Q1, maintaining confidence in growth. Group guidance for FY 2021 confirmed.
Q1 net sales declined -2% (cc¹, +1% USD), due to prior year COVID-19 related forward purchasing (approximately USD 0.4 billion) Pharmaceuticals BU in line with prior year (0% cc, +4% USD) with…

March 2021

Media ReleaseMar 16, 2021
Sandoz in-licenses brand and authorized generic of respiratory medicine Proventil® HFA (albuterol sulfate) Inhalation Aerosol from Kindeva Drug Delivery, with immediate generic availability in US
Albuterol sulfate is used to treat or prevent bronchospasm in patients four years and older with reversible obstructive airway disease, such as asthma, and to prevent exercise-induced bronchospasm1…

February 2021

Media ReleaseFeb 11, 2021
Sandoz announces agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics
Sandoz to acquire three established brands sold in more than 100 markets Acquisition, including leading global brand Zinnat®, confirms Sandoz commitment to antibiotics, following plans to expand its…

January 2021

October 2020

‹ Previous page
1
2
3
4
5
6
7
8
9
…
› Next page